• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: October 22-26, 2012

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

October 22-26, 2012
FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs10/22/12-10/26/12N/AN/AN/ANo Significant Meetings
John M. Taylor, III, J.D., Counselor to the Commissioner10/22/12-10/26/12N/AN/AN/ANo Significant Meetings
Deborah M. Autor, Esq., Deputy Commissioner for Global Regulatory Operations and Policy10/22/12-10/26/12N/AN/AN/ANo Significant Meetings
Virginia Cox, Associate Commissioner for External Affairs10/22/12-10/26/12N/AN/AN/ANo Significant Meetings
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products10/22/12-10/26/12N/AN/AN/ANo Significant Meetings
Elizabeth H. Dickinson, Esq., Chief Counsel10/22/12-10/26/12N/AN/AN/A No Significant Meetings
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine10/23/12Alexandria, VAN/AN/ASpeech at Animal Health Institute Regulator Day
Jesse Goodman, M.D., M.P.H., Chief Scientist10/22/12-10/26/12Rochester, NYN/AN/ARegulatory Science Speaking Engagement at University of Rochester
Walter Harris, Chief Operating Officer10/22/12-10/26/12N/AN/AN/ANo Significant Meetings
Jeanne Ireland, Associate Commissioner for Legislation10/22/12-10/26/12N/AN/AN/ANo Significant Meetings
Michael M. Landa, Director, Center for Food Safety and Applied Nutrition10/22/12-10/26/12N/AN/AN/ANo Significant Meetings
Peter Lurie, Acting Associate Commissioner for Policy and Planning10/22/12-10/26/12Silver Spring, MDSyed Ahmad, Daniel Fabricant, Glenn Peterson, Benjamin Apelberg, Eric Perakslis, Laura Dye, Judy Staffa, James Trinidad, Brooke CourtneyRick Dart, Marsha Ford, Debbie Carr, Michael Dickey, Al Bronstein, David Karnes (American Association of Poison Control Centers)Poison Control Centers Issues
Karen Midthun, M.D., Director, Center for Biologics Evaluation and Research10/22/12-10/26/12N/AN/AN/ANo Significant Meetings
Melinda Plaiser, Acting Associate Commissioner for Regulatory Affairs10/22/12-10/26/12 N/AN/AN/ANo Significant Meetings
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health10/22/12Silver Spring, MDElizabeth Mansfield Ellen Sigal, Jeff Allen (Friends of Cancer)Follow up on September Drug/Diagnostic Meeting
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research10/23/12-10/24/12Jefferson, ARMike Landa and several FDA staffNational Center for Toxicological Research Science Advisory Board; Nigel Walker (National Toxicology Program)Annual Meeting of the National Center for Toxicological Research Science Advisory Board
Stephen Spielberg, M.D., Ph.D., Deputy Commissioner for Medical Products and Tobacco10/23/12Washington, DCN/AN/ANational Organization of Rare Diseases (NORD)/DIA US Conference on Rare Diseases & Orphan Products: Shaping the Future Now
Stephen Spielberg, M.D., Ph.D., Deputy Commissioner for Medical Products and Tobacco10/24/12Silver Spring, MDNancy Stade, Ann WionPam Schaub, Diane Wurzburger (GE Healthcare)Contrast Imaging Indications
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods10/22/12College Park, MDMike Landa, Dennis Keefe, Susan BerndtErik Olson, Maricel Maffini, Tom Neltner (Pew)Food Additives
Mary Lou Valdez, Associate Commissioner for International Programs10/22/12-10/26/12Tallinn, EstoniaKaren Midthun, Joan Blair, Katherine Cooper, Dara CorriganN/A15th International Conference of Drug Regulatory Authorities
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs10/22/12-10/26/12N/AN/AN/ANo Significant Meetings
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research10/24/12Baltimore, MDRon Fitzmartin, Chuck CooperRebecca Kush (CDISC); Carolyn Compton (C-Path); Ann Martin (IMI); Peter Loupos (Sanofi)Coalition for Acclerating Standards and Therapies (CDISC) Interchange Conference
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research10/25/12Silver Spring, MDPatrick Frey, Theresa Mullin, John Jenkins, Donna  Griebel, Patricia Keegan,  Theresa Michele, Ginette Michand, Anne PariserMegan O'Boyle (Phelan-McDermid Syndrome Foundation); Jason Lundy (Critical Path Institute)Public Meeting on Patient-Focused Drug Development